Rispettata la scadenza del Pnrr. Mancano gli infermieri
Risultati per: L’obesità è un fattore di rischio per il cancro del colon-retto
Questo è quello che abbiamo trovato per te
Identificati nuovi biomarcatori per rilevare il cancro del colon-retto
Nessun rischio suicidio da farmaci anti-obesità
Esperti, ‘da depressione ad Alzheimer si studiano nuovi usi”
Da antibiotici e antinfiammatori, legati a minor rischio demenza
Anche alcuni vaccini, tanti composti potrebbero aiutare le cura
Tornano le arance della Salute in 3mila piazze contro il cancro
Il 25 Airc celebra 60 anni d’impegno, 141 milioni alla ricerca
Microbiota-induced S100A11-RAGE axis underlies immune evasion in right-sided colon adenomas and is a therapeutic target to boost anti-PD1 efficacy
Background
Tumourigenesis in right-sided and left-sided colons demonstrated distinct features.
Objective
We aimed to characterise the differences between the left-sided and right-sided adenomas (ADs) representing the early stage of colonic tumourigenesis.
Design
Single-cell and spatial transcriptomic datasets were analysed to reveal alterations between right-sided and left-sided colon ADs. Cells, animal experiments and clinical specimens were used to verify the results.
Results
Single-cell analysis revealed that in right-sided ADs, there was a significant reduction of goblet cells, and these goblet cells were dysfunctional with attenuated mucin biosynthesis and defective antigen presentation. An impairment of the mucus barrier led to biofilm formation in crypts and subsequent bacteria invasion into right-sided ADs. The regions spatially surrounding the crypts with biofilm occupation underwent an inflammatory response by lipopolysaccharide (LPS) and an apoptosis process, as revealed by spatial transcriptomics. A distinct S100A11+ epithelial cell population in the right-sided ADs was identified, and its expression level was induced by bacterial LPS and peptidoglycan. S100A11 expression facilitated tumour growth in syngeneic immunocompetent mice with increased myeloid-derived suppressor cells (MDSC) but reduced cytotoxic CD8+ T cells. Targeting S100A11 with well-tolerated antagonists of its receptor for advanced glycation end product (RAGE) (Azeliragon) significantly impaired tumour growth and MDSC infiltration, thereby boosting the efficacy of anti-programmed cell death protein 1 therapy in colon cancer.
Conclusion
Our findings unravelled that dysfunctional goblet cells and consequential bacterial translocation activated the S100A11-RAGE axis in right-sided colon ADs, which recruits MDSCs to promote immune evasion. Targeting this axis by Azeliragon improves the efficacy of immunotherapy in colon cancer.
Linea guida sulla gestione del sovrappeso e dell’obesità
Carne rossa e rischio demenza: il consumo giornaliero l'accelera, frutta secca e legumi lo riducono
Mangiare carne rossa, specie se lavorata come wurstel e hamburger, aumenta il rischio di demenza e declino cognitivo; per ogni porzione consumata al giorno (circa 85 grammi, come la dimensione…
Rischio fratture, 4% italiani in condizioni di fragilità
Tra over65 100mila ricoveri l’anno, ma cala incidenza in over80
Quando l'obesità diventa malattia, 18 segnali di rischio
Da esperti nuovo metodo diagnosi per cure sempre più su misura
Tumore al colon, l'alcol aumenta il rischio e i latticini lo riducono
Studio, dieta anti cancro da cereali integrali e verdura
Tumore colon, l'alcol aumenta il rischio e i latticini lo riducono
Studio, dieta anti cancro da cereali integrali e verdura
Individuato un nuovo potenziale obiettivo per superare la resistenza al cancro al seno
Caffè, la tazzina al risveglio 'salvacuore',riduce rischio morte
Nessun effetto in altri momenti del giorno
Colonoscopies Outperform New Blood Tests for Colon Cancer Screening
The prospect of avoiding an invasive colonoscopy has helped fuel interest around new less-invasive alternatives to colorectal cancer screenings, such as stool-based tests and cell-free blood-based DNA tests, which received approval from the US Food and Drug Administration (FDA) this past July. But traditional colonoscopies remain the best method for catching colorectal cancer early, according to a study published in the Annals of Internal Medicine.
Ministero Salute, richiamo lotto vongole cotte 'rischio chimico'
Presenza di acido perfluoroottanoico oltre limiti consentiti